By John Halamka and Paul Cerrato - Every clinician knows that early detection is one of the most powerful tools we have in the war on cancer. Several computational tools are enabling us to make early detection a reality, at least in two specialties.

By John Halamka and Paul Cerrato - Two recent studies strongly suggest that sepsis predictive algorithms may in fact be ready for “prime time.”

By John Halamka and Paul Cerrato - A recent report points out that providers are not taking the necessary steps to secure the mobile devices connected to their network.

By John Halamka and Paul Cerrato - A growing number of studies show that drug/gene interactions can influence how patients respond to specific medications. But there are barriers that prevent the full implementation of pharmacogenomic testing into routine clinical practice.

By John Halamka and Paul Cerrato - Concerns about algorithmic bias and poor performance of the models have made many stakeholders more cautious about using these digital tools in patient care. That’s about to change.

Mayo Clinic Platform_Accelerate has announced its second cohort of health tech startups, including national and international businesses. The program will help seven companies develop and validate their artificial intelligence-driven health care products or solutions and advance their business plans.

Mayo Clinic Platform Conference brought together leaders from government, academia, and industry to discuss the future of health care.

By John Halamka and Paul Cerrato - The daily headlines may suggest a dystopian future, but the evidence shows the world is actually becoming a healthier, safer place to live.

By John Halamka and Paul Cerrato - Cognitive errors challenge clinicians and technologists alike. Being aware of the types of mistakes that can occur is the first step toward fixing them.

By John Halamka and Paul Cerrato - The technology, which has been successful used in other industries, is slowly emerging as an innovative way to “clone” organ systems and genomic data to personalize patient care.

By John Halamka and Paul Cerrato - Measuring a long list of biomarkers with the help of wearables, lab testing, medical imaging, and genomic sequencing is the future of precision medicine. Creating these integrative personal omics profiles (iPOPs) has the potential to transform health care.

This collaboration will create an environment that enables rapid product development in the U.S. and Israeli markets, allowing technologies to be established and launched to transform health care delivery for all.